TiclopidinePlatelet Aggregation InhibitorsInfusions, IntravenousDrug Administration SchedulePurinergic P2Y Receptor AntagonistsDouble-Blind MethodTreatment OutcomeDexmedetomidineDose-Response Relationship, DrugAdministration, OralPlatelet Function TestsTime FactorsPlatelet AggregationHalf-LifeDrug Therapy, CombinationInjections, IntravenousAspirinProspective StudiesAntibodies, Monoclonal, HumanizedPsychoses, AlcoholicArea Under CurveThiophenesPremedicationAcute Coronary SyndromeAminophyllineApneaDrug Dosage CalculationsTranexamic AcidDrug InteractionsAbnormalities, MultipleAngioplasty, Balloon, CoronaryFentanylReceptors, Purinergic P2Y12Antifibrinolytic AgentsMetabolic Clearance RateAnalgesics, OpioidAntibodies, MonoclonalPropafenoneHypnotics and SedativesMyocardial InfarctionHydrazonesInfusions, ParenteralStentsAmrinoneAnalgesia, Patient-ControlledDrug MonitoringChromosome AberrationsStress, MechanicalIsoxazolesDrug EvaluationTeicoplaninPlatelet ActivationQuinineElectrocardiographyHeroinInjections, IntramuscularInfant, NewbornFollow-Up StudiesCoronary ThrombosisAnti-Bacterial AgentsPain, PostoperativeAcute DiseaseDogsDisopyramideConscious SedationPiperazinesAntineoplastic Combined Chemotherapy ProtocolsBiomechanical PhenomenaAmiodaroneHemorrhageBlood PressureHemodynamicsMorphineAnticoagulantsCongenital AbnormalitiesCross-Over StudiesAntineoplastic AgentsMagnetic Resonance ImagingThrombosisMidazolamModels, BiologicalChromosome DisordersRadiation DosageHirudinsLethal Dose 50Critical IllnessDrug ResistanceKaryotypingEye AbnormalitiesInfant, PrematureHeart RateRetrospective StudiesNauseaCeftazidimeHeptanoic AcidsPlatelet Glycoprotein GPIIb-IIIa ComplexAntifungal AgentsBlood PlateletsCompressive StrengthPyrroles